Imago BioSciences Balance Sheet Health
Financial Health criteria checks 6/6
Imago BioSciences has a total shareholder equity of $172.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $186.5M and $13.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$178.41m |
| Equity | US$172.62m |
| Total liabilities | US$13.84m |
| Total assets | US$186.46m |
Recent financial health updates
Imago BioSciences (NASDAQ:IMGO) Is In A Good Position To Deliver On Growth Plans
Nov 08
Here's Why We're Not Too Worried About Imago BioSciences' (NASDAQ:IMGO) Cash Burn Situation
Jul 26Companies Like Imago BioSciences (NASDAQ:IMGO) Are In A Position To Invest In Growth
Apr 12We're Not Very Worried About Imago BioSciences' (NASDAQ:IMGO) Cash Burn Rate
Dec 08Recent updates
Imago BioSciences (NASDAQ:IMGO) Is In A Good Position To Deliver On Growth Plans
Nov 08Imago BioSciences GAAP EPS of -$0.41 beats by $0.09
Aug 12Here's Why We're Not Too Worried About Imago BioSciences' (NASDAQ:IMGO) Cash Burn Situation
Jul 26Companies Like Imago BioSciences (NASDAQ:IMGO) Are In A Position To Invest In Growth
Apr 12We're Not Very Worried About Imago BioSciences' (NASDAQ:IMGO) Cash Burn Rate
Dec 08Financial Position Analysis
Short Term Liabilities: IMGO's short term assets ($182.0M) exceed its short term liabilities ($13.8M).
Long Term Liabilities: IMGO has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: IMGO is debt free.
Reducing Debt: IMGO has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: IMGO has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: IMGO has sufficient cash runway for 2.1 years if free cash flow continues to reduce at historical rates of 54.8% each year.